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Abstract
IMPORTANCE Individuals born preterm have increased risk of mental health impairment compared
with individuals born at term. The associations between preterm birth and attention-deficit/
hyperactivity disorder and autism are well established; for depression, anxiety, psychotic and bipolar
disorder, studies show divergent results.
OBJECTIVE To compare the prescription of psychotropic drugs in adolescence and young adulthood
between those born preterm and those born at term.
DESIGN, SETTING, AND PARTICIPANTS This cohort study used registry data to identify all
Norwegians born after 23 weeks of completed gestation between 1989 and 1998. Included
individuals were those without registered birth defects, alive at age 10 years, and with available
maternal data. Individuals were followed up from 2004 to 2016. Psychotropic drug prescriptions
received from age 10 to 23 years were compared between preterm groups and peers born at term.
Individuals were compared with their siblings to control for shared family confounding. Data analyses
were performed from August 2018 through February 2020.
EXPOSURES Gestational age at birth (GA) was categorized in 4 groups: extremely preterm (GA, 23
weeks and 0 days to 27 weeks and 6 days), very preterm (GA, 28 weeks and 0 days to 31 weeks and 6
days), moderately or late preterm (GA, 32 weeks and 0 days to 36 weeks and 6 days), and full term
(GA, 37 weeks and 0 days to 44 weeks and 6 days).
MAIN OUTCOMES AND MEASURES Prescriptions of psychotropic drugs (ie, prescriptions
specifically of psychostimulants, antidepressants, anxiolytics, hypnotics or sedatives, or
antipsychotics or prescriptions of any of these 5 drugs) among preterm groups were compared with
prescriptions among peers born at term and among siblings.
RESULTS Among 505 030 individuals (259 545 [51.4%] males; mean [SD] birth weight, 3533 [580]
g), 762 individuals (0.2%) were extremely preterm, 2907 individuals (0.6%) were very preterm,
25 988 individuals (5.1%) were moderately or late preterm, and 475 373 individuals (94.1%) were full
term. Individuals born preterm had increased risk of psychotropic drug prescription, with a dose-
response association between GA and prescription. The extremely preterm group had higher rates of
prescription for all drug types compared with peers born at term, with odds ratios from 1.7 (95% CI,
1.4-2.1) for antidepressants to 2.7 (95% CI, 2.1-3.4) for psychostimulants. The elevated odds of
prescription of all types were less pronounced in the moderately to late preterm group, including
odds ratios of 1.1 (95% CI, 1.0-1.1) for antidepressants and 1.2 (95% CI, 1.1-1.2) for psychostimulants.
The increases in odds were smaller in the sibling comparison, and increases were not significant for
several groups. For example, the OR for any prescription in the sibling analysis was 1.8 (95% CI,
1.2-2.8) in the very preterm group and 1.0 (95% CI, 0.9-1.1) in the moderately or late preterm group.
(continued)
Key Points
Question Do adolescents and young
adults who were born preterm receive
more prescriptions of psychotropic
drugs compared with those who were
born full term?
Findings In this cohort study in Norway
of 505 030 individuals followed up from
ages 10 to 23 years, all degrees of
preterm birth were associated with
higher rates of prescription of
psychotropic drugs during adolescence
and young adulthood compared with
those born at term.
Meaning These findings provide
further evidence for increased risk of
mental health impairment among
individuals born preterm.
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Abstract (continued)
CONCLUSIONS AND RELEVANCE This cohort study found higher rates of prescription of
psychotropic drugs throughout adolescence and young adulthood among individuals with all
degrees of preterm birth compared with those born at term. These results provide further evidence
for an increased risk of mental health impairment among individuals born preterm and suggest that
this is not restricted to the most preterm groups.
JAMA Network Open. 2021;4(3):e211420. doi:10.1001/jamanetworkopen.2021.1420
Introduction
Children born preterm have an increased risk of neurodevelopmental and cognitive impairment1-3
and mental and social problems.4-12 Findings in studies from 2010 to 201713-15 suggested that the
increased risk of mental health impairment in this population includes increased risk of psychiatric
disorders and increased use of psychotropic drugs. While children born preterm have an increased
risk of attention deficit hyperactivity disorder (ADHD) and autism,5,12,16-20 there is still uncertainty as
to whether they have an increased risk of depression and anxiety21-24 or psychotic and bipolar
disorders,10-12,25 with studies finding divergent results.
The increased risk of mental health impairment among children born preterm is found
throughout their lifespan, from childhood through adolescence and into adulthood.8 However, to
our knowledge, a minority of the studies in this field have targeted adolescence, a period during
which many mental health difficulties emerge.26
The aim of this study was to assess the association between individuals’ degree of preterm birth
and prescriptions of psychotropic drugs during adolescence and into young adulthood. Additionally,
we wanted to assess associations within sibling groups to reduce confounding due to factors shared
within families27-30 and explore how associations for the different drug types varied by age and sex.
Methods
This cohort study was assessed and approved by the Regional Committees for Medical and Health
Research Ethics (REC) and the Norwegian Data Protection Authority. A waiver of informed consent
was granted by REC because of the difficulty of obtaining consent owing to population size. This
study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
reporting guideline for cohort studies.
Study Design
This study was based on a registry data linkage among the Medical Birth Registry of Norway
(MBRN),31 Norwegian Prescription Database (NORPD),32 and Statistics Norway.33 We included all
Norwegians who were born from 1989 through 1998, had a gestational age (GA) of from 23 weeks to
less than 45 weeks, had a birthweight greater than 400 g, had no registered congenital birth defects,
were alive at age 10 years, and had registered maternal variables. We excluded individuals for whom
the size of the discrepancy between birth weight and gestational age suggested that it was most
likely associated with errors in registrations. The MBRN includes virtually all births in the country and
provides information on maternal and neonatal health, education, and demographic characteristics
at birth. The information was linked using a unique personal identification number, and siblings were
identified using the unique identification number for each mother, provided by Statistics Norway.
Information from the NORPD, established in 2004, provided a continuously updated listing of all
prescribed drugs dispensed by pharmacies. Data from Statistics Norway provided dates of
emigration and death.
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Follow-up
All study participants were followed up with annual assessments from 2004 through 2016.
Participants were followed up from age 10 years until the year of emigration, death, or 24th birthday,
whichever occurred first.
Exposure
We measured GA by completed weeks of gestation at birth, as recorded in the MBRN according to
the mother’s last menstrual period. We categorized GA into 4 groups: extremely preterm (GA, 23
weeks and 0 days to 27 weeks and 6 days), very preterm (GA, 28 weeks and 0 days to 31 weeks and
6 days), moderately or late preterm (GA, 32 weeks and 0 days to 36 weeks and 6 days), and full term
(GA, 37 weeks and 0 days to 44 weeks and 6 days).
Outcome
Outcomes were receiving psychotropic drug prescriptions during follow-up period, per data
collected from the NORPD. We defined 5 categories of psychotropic drugs, classified according to the
Anatomical Therapeutic Chemical (ATC) system (eTable 1 in the Supplement): N06A,
antidepressants; N06B, psychostimulants; N05CD, N05CF, and N05CH, hypnotics and sedatives;
N05B, anxiolytics; and N05A, antipsychotics.34 In addition to recording specific prescriptions for
each drug type for individuals, we recorded if individuals were prescribed any of the 5 types.
Prescription status (ie, at least 1 prescription vs no prescription) was recorded each year during
follow-up according to age for each of the 5 types of psychotropic drugs and for any prescription.
Based on these annual registrations, we also constructed measures of prescription vs no prescription
for each of the drug groups for the entire follow-up period (ie, ages 10-23 years), early adolescence
(ie, ages 10-16 years), and late adolescence or early adulthood (ie, ages 17-23 years).
We constructed an alternative outcome for antipsychotics, which most likely were prescribed
for psychotic disorders, by recording high-dose prescriptions for the drugs aripiprazole, olanzapine,
and quetiapine. High dose was defined as more than 180 defined daily doses (DDD) per year; DDD
is an international standardized unity for drug consumption and is defined as the assumed mean
maintenance dose per day for a drug used for its main indication among adults.
Covariates
We included covariates considered as potential confounders in the association between gestational
age and mental health. Child variables collected from the NMBR included sex, birth year, birth
weight, and multiple birth status. We created a z score for birth weight using Marsal et al’s fetal
growth standards35 and identified individuals with birth weights more than 6 SDs less than mean z
score or more than 3 SDs greater than mean z score by gestational age. Maternal variables, including
parity and relationship status, were also collected from NMBR. Maternal age, country of birth, and
highest education attained at the time of the child’s birth were obtained from Statistics Norway.
Details of covariates are presented in eTable 2 in the Supplement. Analyses were performed both
with and without covariates.
Statistical Analysis
In the population sample, we used logistic regression models to compare psychotropic drug
prescription from age 10 to 23 years in each of the preterm groups with prescription in the term
group during the follow-up period. All analyses were repeated for each of the 5 drug types and for
any drug in unadjusted models and models adjusted for participant’s sex, year of birth, multiple birth
status, and birthweight z score and mothers’ parity, relationship status, age in years and age in years
squared, educational level, and country of birth. Analyses were repeated for male and female
participants separately and using alternative outcomes of early prescription (ie, age 10 to 16 years)
and late prescription (ie, age 17 to 23 years). Further adjustment for confounding by parental or family
factors was done by comparing drug prescription vs no prescription within maternal sibling groups
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using conditional logistic regression analyses. All maternal siblings were eligible for the sibling
comparison analysis, but only sibling groups differing in both exposure and outcome status were
used in the calculation of estimates.
To study the development from ages 10 to 23 years, repeated measurements of psychotropic
drug prescription at each age (in years) were compared between each of the preterm groups and the
term group using logistic regression with general estimating equation models. All models were
stratified by sex and adjusted for participant’s year of birth and multiple birth status and mothers’
parity, relationship status, age in years and age in years squared, educational level, and country of
birth. Estimates from these models were used to calculate annual percentages with drug prescription
for each gestational age group at 3-year age intervals from age 10 to 23 years.
We performed sensitivity analyses to explore whether exclusion of individuals who died before
age 10 years or exclusion of birth defects were associated with changes in our outcome estimates.
We performed all analyses using STATA statistical software version 15.1 (StataCorp), and
precision was evaluated with 95% CIs, where estimates within this interval could be described as
compatible with data given the model assumptions. Analyses of data were performed from August
2018 through February 2020.
Results
Among 505 030 individuals included in the analyses (259 545 [51.4%] male participants; mean [SD]
birth weight, 3533 [580] g) (Figure 1), 762 individuals (0.2%) were extremely preterm, 2907
individuals (0.6%) were very preterm, 25 988 individuals (5.1%) were moderately or late preterm,
and 475 373 individuals (94.1%) were full term. Table 1 shows sociodemographic characteristics and
perinatal variables for the study population according to GA group. In the study group, 291 754
individuals (57.8%) had at least 1 maternal sibling in the cohort, clustered within 133 623 sibling
groups with same mother.
Compared with individuals born at full term, individuals born preterm had significantly higher
odds of prescription for all the psychotropic drug groups at ages 10 to 23 years (Table 2), increasing
from the moderately preterm groups to the extremely preterm groups. The unadjusted estimates
Figure 1. Study Population
Statistics Norway: born 1989-1998Medical birth registry: born 1989-1998
2632 Died before age 10 y
11 388 Maternal variables missing
596 848 Individuals identified for study
54 319 Missing gestational age
371 Gestational age <23 wk
1932 Gestational age >44 wk
332 Missing birth weight
17 Birth weight <400 g
3861 Birth weight SD score unlikely (more
than 6 SDs less than or more than
3 SDs greater than mean z score)
16 966 Congenital birth defects
505 030 Followed from age 10 y
762 With GA 23 wk and 0 d to 27 wk and 6 d
With GA 28 wk and 0 d to 31 wk and 6 d
With GA 32 wk and 0 d to 36 wk and 6 d
With GA 37 wk and 0 d to 44 wk and 6 d
2907
25 988
475 373 GA indicates gestational age.
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(Table 2) did not change substantially after adjusting for potential confounding factors (Table 2). The
extremely preterm group had higher odds of being prescribed any kind of psychotropic drug
compared with the term group (adjusted odds ratio [OR], 2.1; 95% CI, 1.8-2.4). Estimates for the
different drug types were similar, with a higher adjusted OR for the extremely preterm group
(antidepressants: OR, 1.7; 95% CI, 1.4-2.1; psychostimulants: OR, 2.7; 95% CI, 2.1-3.4; hypnotics or
sedatives: OR, 1.7; 95% CI, 1.4-2.1; anxiolytics: OR, 2.4; 95% CI, 1.9-3.0; and antipsychotics: OR, 2.4;
95% CI, 1.9-3.2). Estimates were smaller for other preterm groups, including the moderately or late
preterm group (any drug: OR, 1.1; 95% CI, 1.1-1.2; antidepressants: OR, 1.1; 95% CI, 1.0-1.1;
psychostimulants: OR, 1.2; 95% CI, 1.1-1.2; hypnotics or sedatives: OR, 1.1; 95% CI, 1.1-1.2; anxiolytics:
OR, 1.1; 95% CI, 1.1-1.2; antipsychotics: OR, 1.1; 95% CI, 1.1-1.2). Overall findings were similar for male
and female participants (eTable 3 in the Supplement). Estimates from Table 2 are shown in eTable 4 in







late pretermc Full termd All groups
Total 762 (0.2) 2 907 (0.6) 25 988 (5.2) 475 373 (94.1) 505 030 (100)
Sex
Males 381 (50.0) 1621 (55.8) 14 324 (55.1) 243 219 (51.2) 259 545 (51.4)
Females 381 (50.0) 1286 (44.2) 11 664 (44.9) 232 154 (48.8) 245 485 (48.6)
Birthweight, mean (SD), g 901 (202) 1436 (371) 2619 (605) 3600 (498) 3533 (580)
Small for gestational agee 21 (2.8) 235 (8.1) 1597 (6.2) 11 288 (2.4) 13 141 (2.6)
Large for gestational agef 26 (3.4) 84 (2.9) 1234 (4.8) 12 453 (2.6) 13 797 (2.7)
Mother's relationship status
Married or cohabitant 682 (89.5) 2565 (88.2) 23 345 (89.8) 436 425 (91.8) 463 017 (91.7)
Other 80 (10.5) 342 (11.8) 2 643 (10.2) 38 948 (8.2) 42 013 (8.3)
Multiple births
Singletons 583 (76.5) 2190 (75.3) 20 897 (80.4) 467 308 (98.3) 490 978 (97.2)
Twins 150 (19.7) 607 (20.9) 4735 (18.2) 8055 (1.7) 13 547 (2.7)
Triplets or quadruplets 29 (3.8) 110 (3.8) 356 (1.4) 10 (0) 505 (0.1)
Parity
Primiparae 357 (46.9) 1543 (53.1) 12 765 (49.1) 194 932 (41.0) 209 597 (41.5)
Para
1 212 (27.8) 756 (26) 7684 (29.6) 171 450 (36.1) 180 102 (35.7)
2 130 (17.1) 417 (14.3) 3779 (14.5) 81 073 (17.1) 85 399 (16.9)
3 43 (5.6) 145 (5.0) 1229 (4.7) 20 594 (4.3) 22 011 (4.4)
≥4 20 (2.6) 46 (1.6) 531 (2.1) 7 324 (1.5) 7 921 (1.6)
Maternal age, mean (SD), y 29.6 (5.3) 29.2 (5.4) 28.8 (5.3) 28.7 (5.0) 28.7 (5.0)
Maternal education
Primary education 257 (33.7) 960 (33.0) 8504 (32.7) 134 113 (28.2) 143 834 (28.5)
Secondary education 295 (38.7) 1190 (40.9) 10 795 (41.5) 203 424 (42.8) 215 704 (42.7)
Higher education 210 (27.6) 757 (26.0) 6689 (25.7) 137 836 (29.0) 145 492 (28.8)
Maternal country of birth
Norway 685 (89.9) 2627 (90.4) 23 728 (91.3) 439 084 (92.4) 466 124 (92.3)
Other 77 (10.1) 280 (9.6) 2260 (8.7) 36 289 (7.6) 38 906 (7.7)
Psychotropic drugg
Any 239 (31.4) 697 (24.0) 5386 (20.7) 92 462 (19.5) 98 784 (19.6)
Antidepressant 102 (13.4) 286 (9.8) 2359 (9.1) 41 770 (8.8) 44 517 (8.8)
Psychostimulant 82 (10.8) 227 (7.8) 1420 (5.5) 21 467 (4.5) 23 196 (4.6)
Anxiolytic 87 (11.4) 216 (7.4) 1587 (6.1) 26 465 (5.6) 28 355 (5.6)
Hypnotic or sedative 105 (13.8) 313 (10.8) 2546 (9.8) 42 723 (9.0) 45 687 (9.1)
Antipsychotic 59 (7.7) 138 (4.8) 1014 (3.9) 16 821 (3.5) 18 032 (3.6)
Sibling in cohorth 398 (52.2) 1632 (65.1) 15 510 (59.7) 274 214 (57.7) 291 754 (57.8)
a Gestational age, 23 wk and 0 d to 27 wk and 6 d.
b Gestational age, 28 wk and 0 d to 31 wk and 6 d.
c Gestational age, 32 wk and 0 d to 36 wk and 6 d.
d Gestational age, 37 wk and 0 d to 44 wk and 6 d.
e Birth weight <2.5th percentile for gestational age.
f Birth weight >97.5th percentile for gestational age.
g For entire period (ie, ages 10-23 years).
h Individuals with 1 or more maternal siblings in the
study group.
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the Supplement; eTable 3 in the Supplement shows risk differences (marginal effects, with covariates
as observed).
Table 2 also shows the results from the within-sibling analyses. Odds of drug prescription by
gestational age group were lower for most drugs in the sibling analysis compared with the analysis in
the entire study population and were not significant for several drugs in very and moderately or late
preterm groups. For example, the OR for any prescription in the sibling analysis was 1.8 (95% CI,
1.2-2.8) in the very preterm group and 1.0 (95% CI, 0.9-1.1) in the moderately or late preterm group.
In contrast, there were associations between all degrees of preterm birth and prescription of
psychostimulants in the sibling analysis. The OR for psychostimulants in the sibling analysis was 4.0
(95% CI, 1.7-9.1) in the extremely preterm group, 1.9 (95% CI, 1.3-2.9) in the very preterm group, and
1.1 (95% CI, 1.0-1.3) in the moderately or late preterm group.
Figure 2 and Figure 3 illustrate a dose-response association between gestational age and drug
prescription throughout the follow-up period as well as substantial differences in prescription
patterns between male and female participants by age. Prescription of psychotropic drugs increased
with age for the preterm and term groups; however, prescription of psychostimulants decreased
with increasing age. At ages 10 to 12 years and 13 to 15 years, more boys than girls in all gestational age
groups were prescribed any psychotropic medication, with the greatest differences in
psychostimulants (for example, the annual percentage prescribed in the extremely preterm group
was 10.1% (95% CI, 7.4% to 12.6%) in boys and 4.5% (95% CI, 2.5% to 6.4%) in girls at ages 10 to 12
Table 2. Association Between Gestational Age and Prescription of Psychotropic Drugs
Gestational age
OR (95% CI)
Unadjusted Adjusteda Sibling comparison
Any drug
Extremely pretermb 2.0 (1.7-2.3) 2.1 (1.8-2.4) 1.8 (1.2-2.8)
Very pretermc 1.4 (1.2-1.5) 1.4 (1.3-1.5) 1.2 (0.9-1.5)
Moderate/late pretermd 1.1 (1.1-1.1) 1.1 (1.1-1.2) 1.0 (0.9-1.1)
Full terme 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0)
Antidepressant
Extremely pretermb 1.7 (1.4-2.1) 1.7 (1.4-2.1) 1.2 (0.6-2.2)
Very pretermc 1.2 (1.1-1.4) 1.2 (1.1-1.4) 1.1 (0.8-1.5)
Moderately or late pretermd 1.1 (1.0-1.1) 1.1 (1.0-1.1) 1.0 (0.9-1.1)
Full terme 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0)
Psychostimulant
Extremely pretermb 2.5 (2.0-3.2) 2.7 (2.1-3.4) 4.0 (1.7-9.1)
Very pretermc 1.7 (1.5-2.0) 1.7 (1.5-2.0) 1.9 (1.3-2.9)
Moderately or late pretermd 1.2 (1.1-1.3) 1.2 (1.1-1.2) 1.1 (1.0-1.3)
Full terme 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0)
Hypnotic or sedative
Extremely pretermb 1.6 (1.3-2.0) 1.7 (1.4-2.1) 1.5 (0.9-2.6)
Very pretermc 1.3 (1.1-1.4) 1.3 (1.1-1.4) 1.0 (0.7-1.3)
Moderately or late pretermd 1.1 (1.1-1.2) 1.1 (1.1-1.2) 1.0 (0.9-1.2)
Full terme 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0)
Anxiolytic
Extremely pretermb 2.3 (1.8-2.9) 2.4 (1.9-3.0) 2.2 (1.1-4.1)
Very pretermc 1.4 (1.2-1.7) 1.5 (1.3-1.7) 1.1 (0.8-1.6)
Moderately or late pretermd 1.1 (1.1-1.2) 1.1 (1.1-1.2) 1.0 (0.9-1.1)
Full terme 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0)
Antipsychotic
Extremely pretermb 2.4 (1.8-3.1) 2.4 (1.9-3.2) 1.8 (0.8-4.1)
Very pretermc 1.4 (1.2-1.7) 1.4 (1.2-1.7) 1.3 (0.9-1.9)
Moderately or late pretermd 1.1 (1.1-1.2) 1.1 (1.1-1.2) 1.1 (0.9-1.3)
Terme 1.0 (1.0-1.0) 1.9 (1.0-1.0) 1.0 (1.0-1.0)
a Adjusted for participant’s year of birth, multiple birth
status, and birthweight z score and mothers’ parity,
relationship status, age in years and age in years
squared, educational level, and country of birth.
b Gestational age, 23 wk and 0 d to 27 wk and 6 d.
c Gestational age, 28 wk and 0 d to 31 wk and 6 d.
d Gestational age, 32 wk and 0 d to 36 wk and 6 d.
e Gestational age, 37 wk and 0 d to 44 wk and 6 d.
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years). In contrast, at ages 19 to 21 years and 22 to 23 years, the situation was reversed, with a greater
increase in psychotropic prescriptions over time for female participants than for male participants in
all gestational age groups, with the greatest increase in antidepressants. For example, the estimated
percentage with annual prescriptions of antidepressants in the extremely preterm group increased
by 12.6 percentage points (95% CI, 9.1 percentage points to 16.1 percentage points) in females and
4.4 percentage points (95% CI, 2.1 percentage points to 6.8 percentage points) in males from ages 10
to 12 years to ages 22 to 23 years. Corresponding increases in the full-term group were 5.7 percentage
points (95% CI, 5.6 percentage points to 5.8 percentage points) for females and 2.8 percentage
points (95% CI, 2.7 percentage points to 2.9 percentage points) for males.
Additional Analyses
Results for drug prescription during age periods 10 to 16 years and 17 to 23 years for male and female
participants separately (eTable 5 in the Supplement) are similar to the main results (Table 2).
However, ORs were higher for prescriptions of most drugs for preterm boys during age period 10 to
16 years.
To assess whether the observed use of antipsychotics was associated with psychosis, we
performed analyses on the alternative outcome of antipsychotics. Although only 2018 individuals
(0.4% of the population sample and 11% of individuals prescribed antipsychotic drugs) received
aripiprazole, olanzapine, or quetiapine at high doses (ie, >180 DDD for at least 1 year), the odds of

























































































































































23-27 wk 28-31 wk 32-36 wk 37-44 wk
JAMA Network Open | Pediatrics Preterm Birth and Psychotropic Drug Use in Adolescence and Young Adulthood
JAMA Network Open. 2021;4(3):e211420. doi:10.1001/jamanetworkopen.2021.1420 (Reprinted) March 12, 2021 7/13
Downloaded From: https://jamanetwork.com/ by a Norwegian Institute of Public Health User  on 10/08/2021
such prescription were increased for the extremely preterm group (OR, 3.5; 95% CI, 1.9-6.6)
compared with the full-term group. There were too few individuals for sibling comparison.
Sensitivity analyses found that 1313 children (37.9%) among 3467 children in the original
population sample (before exclusion) who died before age 10 years were born preterm; 1210 of them
(92.2%) died before age 1 year (eTable 6 in the Supplement). In analyses of the group including
individuals with congenital birth defects, there was no change the association between GA and
prescription of any of the studied drugs (eTable 7 in the Supplement).
Discussion
This cohort study found higher rates of prescription of psychotropic drugs among adolescents and
young adults born preterm compared with their peers born at full term, an indicator associated with
mental health impairment in this group. Adolescents and young adults born preterm had higher
odds, compared with those born at full term, for prescription of all psychotropic drugs studied:
antidepressants, psychostimulants, anxiolytics, hypnotics and sedatives, and antipsychotics. Odds
were greatest for extremely and very preterm birth groups but was also found for moderately or late
preterm groups. There was no change in this association after adjustment for perinatal and parental
factors. In analyses comparing siblings, odds were high for extremely preterm birth groups, while
lower or not significant for very preterm birth groups and moderately or late preterm birth groups.
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These findings suggest that confounding factors may play a significant role in the associations under
study in these groups. There were some differences in the size of the estimates among male and
female participants at different ages, with greater relative odds increases for drug prescription
among younger male participants and the largest absolute differences between gestational age
groups for prescription of antidepressants among older female participants.
Findings Compared With Existing Knowledge
Our findings support much of the existing knowledge about preterm birth and the risk of social
problems and mental health issues in adolescence and young adulthood. We found associations
between preterm birth and prescription of psychotropic drugs, reconcilable with findings from
cohort studies from 20165 and 201741 and population-based registry studies from 2009 to 2013.11-14
It has been debated to what extent preterm births are associated with an increased risk of
psychotic disorders, an association that research from 2008 to 2013 may suggest.1,10-14 D’onofrio
et al12 found that family conditions were associated with much of this increase in risk but not all. We
found, as did a Swedish study from 201014 looking at prescriptions, a dose-response association
between degree of preterm birth and prescription of antipsychotic drugs for all ages. However, the
ATC group N05A contains several antipsychotic drug types, which are prescribed on various
indications. The finding in the present study of a 3-fold increase in odds for prescriptions of
aripiprazole, olanzapine, and quetiapine given at high doses in the extremely preterm group may
suggest increased risk of psychotic disease in this group. However, this finding must be interpreted
with caution given that only 0.4% of the study population received this kind of antipsychotic
prescription.
For the group born extremely preterm, estimates from the sibling comparison suggested that
the risk of mental health impairment during adolescence and young adulthood may be associated
with their premature births. Mental health impairment among individuals born preterm is usually
explained by complex interplay among prenatal and perinatal factors, including disturbed brain
development and stress responses. The process of injury, often referred to as encephalopathy of
prematurity, is associated with inflammation, hypoxic-ischemic lesions, and dysmaturation in the
preterm brain, and related to white matter disease and changes in gray matter in the cortex and the
deep nuclei.42 In addition, being born preterm is often associated with more health care contacts
throughout childhood, owing to standardized follow-up programs initiated by the health care
system43 and increased morbidity. This could be associated with increased awareness and detection
of potential adverse outcomes associated with preterm birth, including increased diagnosis of mental
disorders and prescription of psychotropic drugs for the most preterm individuals.
The association between GA and prescription in our study was found not only for extremely and
very preterm birth, but also for moderately or late preterm groups. For these preterm birth groups
(GA, 32 weeks-36 weeks) recent studies have found an increased psychiatric morbidity in
adolescence and adulthood, including hospital admissions for psychiatric disorders and psychiatric
diagnoses.11,44
Similar to the results from other studies, our findings suggest that there may be different
mechanisms associated with different types of conditions. D’onofrio et al12 found associations
between GA and ADHD and autism, but after adjusting with sibling analyses, the increases in risks
were smaller for bipolar and psychotic disorder and there was no significant increase in risks for
suicide or receipt of social welfare benefits. Lindström et al18 also found an unchanged association
between GA and use of drugs for ADHD when comparing siblings. This is consistent with our findings,
which suggest that many of the mental and social conditions found in the preterm population, with
the exception of ADHD, could be associated with confounding factors in the environment or
genetics, especially for the later preterm groups. There is evidence suggesting that children born
preterm from households with low socioeconomic status are at greater risk for mental health
impairment.11 This association has been a subject of debate, and a possible explanation for our
findings might be that confounding factors play an increasing role with increasing GA. The findings in
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prescription of psychotropic drugs from ages 10 to 23 years in this study add detail and nuance to
existing knowledge. We have not been able to find other similar studies of how the increased use of
psychotropic medication for children born preterm varies by drug type, sex, and age. Of particular
interest was the prominent increase in prescriptions from ages 16 to 18 years and 19 to 21 years found
among female participants born extremely preterm .
Strengths
Strengths of our study include the study design, with a large, naturally selected population
distributed across all gestational ages, with the possibility to follow up all participants using high-
quality registry data, along with the opportunity to study the population over several years and
across participants’ youth. Using sibling design made it possible to adjust for confounding factors
shared by siblings.
Limitations
This cohort study has several limitations. In our registry data, term date was determined based on the
mothers last menstrual period, which is a less exact method than using ultrasound
measurement.36-38 The method based on menstrual period has been shown to be associated with
overestimations of the true gestational age by 2 or 3 days. However, we consider such
misclassification as nondifferential, which would most likely bias the results from the population
analyses toward the null.
Prescriptions of a psychotropic drug provides little information about specific psychiatric
diagnoses. However, we consider it a sensitive measure of mental health difficulties.39
Even if sibling comparison may be an effective way of accounting for unmeasured confounding
associated with family background, it has been suggested that this approach may increase selection
bias and measurement error.40 Random measurement error in the assessment of gestational age
may thus be increased when comparing siblings and may lead to an attenuation of estimates in the
sibling comparison. However, we consider error in the measurement of gestational age a minor issue
owing to standardized procedures and registration.
We had no knowledge of diagnoses other than perinatal conditions, which makes it difficult to
rule out confounding from other comorbid conditions present at birth but diagnosed later.
Additionally, these findings may primarily be valid only for survivors, because only those alive at
age 10 years were followed. Individuals born preterm were overrepresented among those who died,
and we expect that if survival were greater among these individuals, the prescription of psychotropic
medication found in our study would also have increased.
Conclusions
This cohort study found that the prescription of psychotropic drugs was higher among adolescents
and young adults who were born preterm compared with those born at term. Children born preterm
have increased mental and social risks in adolescent and young adult years. This increased risk may
be largely associated with factors involving genetics and childhood environment for the later preterm
groups. Trajectories established during adolescence are associated with later mental health status
and lifetime opportunities, and this period could thus be an important target for health-promoting
measures and preventive measures for this group.
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